A wide variety of b-lactam antibiotics are used in the treatment of infectious diseases. These antibiotics block the cell wall biosynthesis of bacteria by inhibiting a transpeptidase. However, bacteria have developed several strategies for resisting b-lactam antibiotics, including the production of a family of enzymes, b-lactamases. The b-lactamases catalyze the hydrolysis of b-lactam antibiotics, opening the b-lactam ring and rendering the antibiotics inactive.
1-3)
b-Lactamases have been grouped into four molecular classes, A, B, C and D, based on their amino-acid sequence homologies by Ambler et al. 4) Those that belong to classes A, C and D are serine-b-lactamases which use serine as the active site to facilitate catalysis, and those that belong to class B are metallo-b-lactamases (MBLs) that contain one or two zinc ions at the active site to facilitate b-lactam cleavage. Based on the difference in their primary structures, MBLs have been classified into three subfamilies, 5) B1 (BcII from Bacillus cereus, 6) CcrA from Bacteroides fragilis, 7) IMP-1 from Serratia marcescens, 8) VIM-2 from Pseudomonas aeruginosa 9) ), B2 (CphA from Aeromonas hydrophila AE036 10) ), and B3 (L1 from Stenotrophomonas maltophilia 11) ). MBLs are able to hydrolyze most of the b-lactam antibiotics [6] [7] [8] [9] [10] [11] and pose a serious clinical threat because of their ability to degrade carbapenems including imipenem and meropenem, which are not degraded by most serine-b-lactamases. [1] [2] [3] The genes that encode IMP-1 and VIM-2 have been found to be located in plasmids that are horizontally transferable to other bacteria 8) and no clinically available inhibitors for them exist at present.
IMP-1 consists of an ab/ba motif, and two Zn(II) ions are located at the bottom of a wide shallow groove between the b-sheets. 12) One of the Zn(II) ions is coordinated by three histidine residues (3H site), and the other is coordinated by His, Asp, Cys residues and water-2 molecule (DCH site). In addition, the water-1 molecule would be expected to bridge the two Zn(II) ions presumably in the form of a hydroxide ion, although this is not confirmed in the three-dimensional structure of IMP-1 but is based on the three-dimensional structure of CcrA (PDB 1ZNB). 13) VIM-2 was isolated from Pseudomonas aeruginosa in 1996 in France, 9) and has also been identified recently in Japan. 14) On the basis of amino acid sequences, 31% of the residues are identical in these enzymes, indicating that VIM-2 9) and IMP-1 8) retain the binuclear metal binding motif where Zn(II) ions are coordinated by the side chains of conserved amino acids. The amino acid sequences of a flexible loop, a b-sheet flap, which is thought to be important in the binding of particular inhibitors and substrates, are different between IMP-1 and VIM-2 especially in the nature and position of the hydrophobic amino acid: Trp28 which is located in the edge of the flap in the case of IMP-1 but is replaced with Ala in VIM-2.
A number of compounds have been examined as inhibitors of MBLs since 1996, including trifluoromethyl alcohols and ketones, 15) hydroxamates, 16) thiols, [17] [18] [19] [20] [21] [22] [23] [24] [25] thioester derivatives, 19, [26] [27] [28] [29] cysteinyl peptides, 30) biphenyl tetrazoles, 31, 32) mercaptocarboxylates, 12, 21, 29) 1b-methylcarbapenem derivatives, 33, 34) 2,3-disubstituted succinic acid derivatives, 35) tricyclic natural products, 36) sulfonyl hydrazones, 37) and a synthetic cephamycin. 38) Most of these compounds, however, have been shown to exert their adverse effects only on a limited number of MBLs.
The X-ray crystal structures of MBLs complexed with inhibitors have been reported, including CcrA-4-morpholineethanesulfonic acid, 39) CfiA-tricyclic natural products, 36) IMP-1-mercaptocarboxylate, 12) 2,3-disubstituted succinic acid derivatives, 35) BlaB-D-captopril, 40) and FEZ-D-captopril. 41) From these reports, these enzymes have conserved the amino acid residues and the binuclear metal center at the ac- 17) The thiol group of inhibitors was assumed to coordinate with the metal ions in the active site, and this was supported by an X-ray crystallographic analysis of 2-[5-(1-tetrazolyl-methyl)thien-3-yl]-N-[2-(mercaptomethyl)-4-(phenylbutyrylglycine)] and the IMP-1 complex. 12) A fluorescent probe of IMP-1 having a dansyl and a thiol group, DansylC2SH, has recently been reported by our group. 25) The fluorescent probe also functions as a potent inhibitor of IMP-1. The dansyl group appears to interact with hydrophobic groups near the active site of IMP-1.
In this study, we used three functional groups to strengthen the interactions with MBLs: a thiol group, presumed to bind with Zn(II) ions, an aromatic ring to bind with the hydrophobic pocket, and a carboxyl group to interact via hydrogen bonding or electrostatic interactions with conserved residues, such as Lys. Three types of compounds that contain the three functional groups above, PhenylCnSH, QuinolineCnSH, and DansylC2SH shown in Fig. 1 were examined as inhibitors of IMP-1 and VIM-2.
MATERIALS AND METHODS

Materials
The bla IMP gene is derived from S. marcescens TN9160 42) and was cloned into pKF19k (denoted as pKF19k/IMP). The construction of pKF19k/IMP will be reported elsewhere.
43) The P. aeruginosa strain NCB326 was isolated from the drainage fluid of a liver abscess patient in 1999 in Nara, Japan. BamHI digested fragments of wholecell DNA from P. aeruginosa NCB326 were ligated into the BamHI-restricted plasmid pBCSK(ϩ) (Stratagene, La Jolla, Calif., U.S.A.). Recombinant plasmids were introduced by electroporation into E. coli HB101 competent cells. E. coli NCB326-1B2 carried a recombinant plasmid pVM4k (named pVM4k/VIM-2) and this transformant successfully produced a VIM-2 metallo-b-lactamase.
Construction of Expression Vectors, pET9a/IMP The over-expression of IMP-1 metallo-b-lactamase in E. coli was achieved as follows: the bla IMP gene without the nucleotide coding the signal peptide was amplified using two primers IMP-NdeI (5Ј-TTCCTTTCATATggCAgAgTCTTTgCCA gATTT-3Ј), which was designed to add NdeI linker (underlined), and IMP-BamHI (5Ј-gTTggATCCTAgAAATT TAgTTgCTTggTTTTgATggT-3Ј), designed to add the BamHI linker (underlined). PCR was performed with 350 ng of template DNA (plasmid pKF19k/IMP), 50 pmol of each primer, 2.5 U of taq DNA polymerase (TaKaRa Bio INC., Shiga, Japan) in a final volume 100 ml in the buffer system provided by the manufacturer. The resulting PCR product was digested with NdeI and BamHI and cloned in pET9a (Novagen, Madison, Wis.), digested with the same enzymes, to give the recombinant plasmid. The constructed expression vectors, denoted as pET9a/IMP, were introduced into E. coli BL21 (DE3) (Novagen).
Expression and Purification of the IMP-1 Enzymes E. coli BL21 (DE3), carrying plasmids pET9a/IMP, was cultured in 10 l of LB broth supplemented with kanamycin (50 mg/ml). At an Abs 600 of 3, isopropyl-b-D-thiogalactopyranoside (IPTG) was added, at final concentration of 1 mM, and the culture was further incubated for 8 h. Cells were harvested by centrifugation and suspended in 30 ml of 50 mM phosphate buffer (pH 7.0, containing 100 mM Zn(NO 3 ) 2 ) and disrupted by sonication (60 cycles, each cycle for 5 s at 1 min intervals), then centrifuged at 150000ϫg for 60 min at 4°C. The cleared supernatant was used in the subsequent chromatographic purification, as described previously.
44) The purity of the enzyme was verified by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie blue staining. Final preparation showed a single band with more than 95% purity.
Production and Purification of VIM-2 VIM-2 was expressed by E. coli NCB326-1B2 harboring pVM4k/VIM-2 and purified using methods described by Poirel et al. in 2000.
9)
E. coli NCB326-1B2 carrying plasmids pVM4k/VIM-2 was cultured in 10 l of LB broth supplemented with ABPC (50 mg/ml). The culture was incubated for 12 h at 37°C (Abs 600 was 1.0). Cells were harvested by centrifugation and suspended in 30 ml of 50 mM Bis-Tris buffer (pH 6.5, containing 10 mM Zn(NO 3 ) 2 ) and disrupted by sonication (60 cycles, each cycle for 5 s in a minite), then centrifuged at 150000ϫg for 60 min at 4°C. The cleared supernatant was used in the subsequent chromatographic purification. Anionexchange chromatography was performed on a Q-Sepharose Fast Flow (Pharmacia Biotech, Uppsala, Sweden, f26 mmϫ 100 mm) preequilibrated with 50 mM Bis-Tris buffer (pH 6.5, containing 10 mM Zn(NO 3 ) 2 ) and was eluted with a linear gradient of 0 to 0.3 M NaCl in 50 mM Bis-Tris buffer (pH 6.5, containing 10 mM Zn(NO 3 ) 2 ). Fractions containing b-lactamase activity were collected, concentrated and the buffer changed to 50 mM phosphate buffer (pH 7.0, containing 2 mM Zn(NO 3 ) 2 ) containing 0.3 M NaCl, were applied to a gelfiltlation column, Sephadex G-75 (Pharmacia Biotech, Uppsala, Sweden, f50 mmϫ800 mm), preequilibrated with 50 mM phosphate buffer (pH 7.0, containing 2 mM Zn(NO 3 ) 2 ) containing 0.3 M NaCl. The purified enzyme was used in subsequent b-lactamase assays. The purity of the preparation was checked by SDS-PAGE, and final preparation showed a single band with more than 95% purity. The molecular weight of purified VIM-2, M r ϭ29.7 kDa as SDS-PAGE, was in agreement with the reported value. 9) rate of consumption of a chromophoric substrate, nitrocefin, by IMP-1 (VIM-2). A solution (3.1 ml) of nitrocefin (100 mM) in 50 mM Tris-HCl buffer (pH 7.4, 0.5 M NaCl) was incubated at 30°C for 5 min. The enzyme solution of 0.4 mM IMP-1 (VIM-2) (10 ml) was added to the substrate solution and the increase in absorbance at 491 nm (Deϭ20000) was recorded. Enzymic rate parameters, K m and k cat , were determined by a nonlinear least-squares method (Kaleida graph) to fit the Michaelis-Menten equation.
Determination of IMP-1 and VIM-2 The concentrations of IMP-1 and VIM-2 were determined from the absorbance at 280 nm: e 280 ϭ49000 M Ϫ1 cm Ϫ1 for IMP-1 and e 280 ϭ32000 M Ϫ1 cm Ϫ1 for VIM-2. PhenylCnSH (n‫)4-1؍‬ PhenylCnSH (nϭ1-4) were prepared using a method described by Park J. D. et al. 45) QuinolineC3SH, N-[3-(7-Chloro-quinolin-4-ylamino)-propyl]-3-mercapto-propionamide 4,7-Dichloroquinoline (1.64 g, 0.0083 mol) was added to 1,3-diaminopropane (6.15 g, 0.083 mol). After refluxing at 100°C for 4 h, the mixture was concentrated to give the crude product, which was chromatographed with a Wakogel C-300 (Silica Gel) column by elution with methanol : chloroform : 28% aqueous ammoniaϭ40 : 360 : 1 to give a yellow solid (1.65 g, 84.5%).
To the yellow solid (1.54 g, 0.0065 mol) and BPO reagent (benzotriazol-1-yloxytris-(dimethylamino) phosphonium hexafluorophosphate) (2.88 g, 0.0065 mol) dissolved in 150 ml of chloroform, 3-mercaptopropionic acid (0.69 g, 0.0065 mol) and triethylamine (1.76 g, 0.017 mol) were added. The mixture was stirred under argon at room temperature overnight and concentrated under reduced pressure to give a pale yellow solid. This was purified by Wakogel C-300 (Silica Gel) column chromatography eluted with the solution containing methanol, chloroform, and 28% aqueous ammonia (40 : Inhibition of IMP-1 and VIM-2 A portion of 0.1 ml of an inhibitor [PhenylCnSH (nϭ1-4), DansylCnSH (nϭ2), QuinolineCnSH (nϭ2-6)] at various concentrations in methanol and 0.01 ml of 310 nM enzyme (IMP-1 and VIM-2) in 50 mM Tris-HCl (pH 7.4, 0.5 M NaCl) was added to 2.9 ml of 50 mM Tris-HCl buffer (pH 7.4, 0.5 M NaCl). The enzymeinhibitor mixture was incubated for 10 min at 30°C, and a 0.1 ml DMSO solution of 3.1 mM nitrocefin was then added and the absorbance change at 491 nm monitored for 3 min. Methanol was used instead of an inhibitor as a control.
The molar activity, k 2 /min Ϫ1 , was determined from the initial velocity, v, by v/ [E] , and plotted against the concentration of the inhibitors. IC 50 values were determined from this and K i values were determined by fitting k 2 to a competitive inhibition of Eq. 1 using K m values of 20 mM and 22.5 mM for IMP-1 and VIM-2 respectively, (1) where, k 2 : molar activity, k 2max ϭV max /[E], V max ϭthe maximum velocity.
Fluorescence Titration of IMP-1 with QuinolineCnSH (n‫)6-2؍‬ The method used to examine fluorescence reported by Kurosaki et al. 25) was used in this experiment. Flu-
orescence spectra were measured at 25°C, with a 5.0 nm of slit width, using 1 mM of QuinolineCnSH (nϭ2-6) as a fluorescence agent with an excitation of 340 nm and 280 nm using 50 mM Tris-HCl buffer (pH 7.4, 0.5 M NaCl) containing 10% of methanol.
RESULTS
K i (Inhibition Constant) and IC 50 (50% Inhibitory Concentration) of Inhibitors agaist IMP-1 and VIM-2
Using nitrocefin as a substrate, the molar activity k 2 /min Ϫ1 in the presence of each inhibitor was obtained from the initial rate measurement and was plotted against the concentration of each inhibitor, (PhenylCnSH (nϭ1-4), DansylCnSH (nϭ2), and QuinolineCnSH (nϭ2-6)). Typical plots are shown in Fig. 2 (IMP-1 and VIM-2) . Values for the IC 50 of IMP-1 and VIM-2 were calculated from these concentration response curves. Inhibition constants, K i , were determined by fitting the kinetic data to that for the competitive inhibition using Eq. 1.
Inhibition by PhenylCnSH (n‫)4-1؍‬ PhenylCnSH (nϭ1-4) were synthesized and tested as inhibitors of carboxypeptidase A (CPA), a Zn(II) enzyme, by Park et al. 45) The IC 50 and K i values for IMP-1 and VIM-2 are listed in Table 1 .
The IC 50 s for IMP-1 were found to be in a range between 1.2 mM (PhenylC4SH) and 16.4 mM (PhenylC1SH), and the inhibition constants, K i , had values between 0.21 mM (PhenylC4SH) and 2.78 mM (PhenylC1SH). When the number of methylene units in the linker was varied, PhenylC4SH was found to inhibit IMP-1 more strongly among PhenylCnSH (nϭ1-4). 3-Mercaptopropionic acid has been reported to have a K i value of 1.2 mM to IMP-1. 17) In comparison, PhenylC4SH was found to be a more potent inhibitor.
IC 50 values for VIM-2 were found to be in a range between 1.1 mM (PhenylC4SH) and 14.3 mM (PhenylC1SH). The inhibition constants, K i , have values between 0.19 mM (PhenylC4SH) and 2.36 mM (PhenylC1SH). PhenylCnSH (nϭ1-4) were found to be potent inhibitors of VIM-2 as well as of IMP-1. When the number of methylene units of the linker was varied, PhenylC3SH and PhenylC4SH was also the potent inhibitor of VIM-2.
PhenylCnSH (nϭ1-4) were found to be potent inhibitor for both IMP-1 and VIM-2, and a comparison of the inhibition constant K i for PhenylCnSH (nϭ1-4) for IMP-1 and VIM-2 is shown in Fig. 3 . The dependency of the inhibitory effect on the number of methylene units of the linker, n, is different for IMP-1, compared to VIM-2. PhenylC4SH inhibits both IMP-1 and VIM-2 more strongly and PhenylC1SH the most weakly. VIM-2 is as susceptible when nϭ2 and nϭ3 as nϭ4 but the susceptibility of IMP-1 is significant only for nϭ4.
Inhibition by a Fluorescent Probe, DansylCnSH (n‫)2؍‬ A fluorescent probe, DansylC2SH for IMP-1, containing a thiol group and a dansyl group was synthesized, and reported as potent inhibitor for IMP-1. 25) DansylC2SH (nϭ2) inhibited IMP-1 and VIM-2: the IC 50 values were 2.3 mM and 5.2 mM, the inhibition constant K i was 0.42 mM and 1.1 mM for VIM-2 and IMP-1.
25)
QuinolineCnSH (n‫)6-2؍‬ An increase in fluorescence intensity was found on the addition of IMP-1 to DansylC2SH, but the addition of IMP-1 to QuinolineCnSH led to a decrease in fluorescence intensity. A comparison of structures of QuinolineCnSH and with that of DansylC2SH shows that the sulfonyl group between the quinoline group, a fluorescence group, and the HN group is missing in QuinolineCnSH.
The IC 50 and K i values for IMP-1 and VIM-2 are listed in Table 1 .
QuinolineCnSH (nϭ2-6) act as effective inhibitors against IMP-1 and VIM-2. The IC 50 for IMP-1 was found to be in a range between 2.5 mM (QuinolineC4SH) and 14.2 mM (QuinolineC2SH). The inhibition constants, K i , have values between 0.44 mM (QuinolineC4SH) and 2.97 mM (QuinolineC2SH). The IC 50 for VIM-2 was found to be in a range between 2.4 mM (QuinolineC4SH) and 7.6 mM (QuinolineC5SH). The inhibition constants, K i , have values between 854 Vol. 27, No. 6 0.42 mM (QuinolineC4SH) and 1.39 mM (QuinolineC5SH). When the number of methylene units was varied, QuinolineC4SH showed the maximum inhibitory activity against both IMP-1 and VIM-2, as shown in Fig. 3 . The magnitude of K i decreased with the number of methylene units from 2 to 4 for IMP-1, but remained unchanged for VIM-2.
DISCUSSION
PhenylCnSH (nϭ1-4) and QuinolineCnSH (nϭ2-6) are found to be potent inhibitors for MBLs in this study.
The following interactions of PhenylCnSH (nϭ1-4) with IMP-1 and VIM-2 would be predicted: 1) replacement of the water-1 between the two Zn(II) ions with the thiol group in the active site, 2) hydrogen bonding of the oxygen of the carboxyl group with amino acids of the enzyme or replacement of water-2 coordinated to the Zn(II) ion in the DCH site, 3) hydrophobic interactions between the phenyl group and the hydrophobic pockets of MBLs.
1) The thiol group of PhenylCnSH (nϭ1-4) inhibitors appears to bind with Zn(II) ions of the active site of MBLs. This was supported by the X-ray crystallographic analysis of a complex of IMP-1 with a thiol compound. 12) 2) The phenyl group of PhenylCnSH (nϭ1-4) may interact with hydrophobic amino acid(s) near the active site. The phenyl ring of PhenylC4SH is located at a sufficient distance to effect hydrophobic interactions with a hydrophobic pocket near the active site of IMP-1. PhenylC3SH and PhenylC4SH inhibit both IMP-1 and VIM-2 more strongly, and PhenylC2SH was found to strongly inhibit VIM-2 to a greater extent than IMP-1. These results suggest that the hydrophobic pocket of VIM-2 is larger than IMP-1, and is located near the Zn(II) site. PhenylC1SH showed only a weak inhibition for VIM-2. When the number of methylene units is 3 and 4, it can be considered to be a suitable distance for interacting with the hydrophobic pocket of VIM-2 (Fig. 3) .
For the case of the inhibition of CPA by PhenylCnSH (nϭ1-4), the K i of PhenylCnSH (nϭ1-4) was determined to be 0.010, 2.1, 1.35, and 1.3 mM respectively. 45) PhenylC1SH inhibits CPA most strongly by electrostatic interactions between the oxygen of the carboxyl group and the ionic side chain of CPA as well as binding of the thiol with Zn(II) and hydrophobic interactions. Although PhenylC4SH inhibited most strongly, the K i values for IMP-1 and VIM-2 are not greatly different from the others with respect to CPA. The observation that PhenylCnSH (nϭ1-4) inhibited both of IMP-1 and VIM-2 indicates that these compounds are inhibitors of other MBLs.
A comparison of the inhibition constants and structures of other inhibitors are shown in Fig. 4 .
Although only the thiol group of PhenylC1SH is replaced with a carboxyl group for inhibitor B, a 2,3-disubstituted succinic acid, reported by Toney 35) a large difference in the IC 50 : 16.4 mM was found for PhenylC1SH and 490 mM by B for IMP-1 when the substrate was nitorocefin. This suggests that a thiol group is a very important group in terms of inhibiting MBLs. PhenylC4SH was the potent inhibitor of IMP-1 among the PhenylCnSH series. However, Mollard reported that inhibitor C has a K i value of 29 nM 23) lower by 10 fold than PhenylC4SH. We have reported that mercaptoacetic acid is a reversible inhibitor with a K i of 0.23 mM.
17) Inhibitor C having the phenyl group on C2 position of mercaptoacetic acid led to approximately 10 fold high activity compared to mercaptoacetic acid. This higher K i may reflect much higher hydrophobic Toney et al. have reported that the addition of the benzyl group at C3 position of inhibitor B increases K i by 1.8ϫ10 5 fold (0.0027 mM) compared to inhibitor B.
35)
Although QuinolineCnSH could not be used for the detection of MBLs by fluorescence, QuinolineCnSH are potent inhibitors for both IMP-1 and VIM-2.
For both PhenylCnSH and QuinolineCnSH, the inhibitory effect is maximum for nϭ4 for IMP-1 and VIM-2 and least for nϭ1 for IMP-1. But the effect of variation in the number of methylene units in the linker, n, is different between IMP-1 and VIM-2. The thiol group acts as a coordinating ligand of one of the two Zn(II) ions or both as a bridging ligand and provides strong driving force for binding with the active center. However, for being a good or relevant inhibitor, candidate compounds should be involved in specific interactions around the environment of the active site. The phenyl group in PhenylCnSH and the quinoline group in QuinolineCnSH are intended to interact with the hydrophobic region of the enzymes. The dependency of the inhibitory effect on the number of the methylene (n) reflects the difference in the geometry of MBL: IMP-1 has a narrower or tighter hydrophobic pocket than VIM-2.
